Skip Navigation Change Font Size

Audit (A-07-11-06029)

01-18-2012
Review of Controls at SilverScript Insurance Company to Ensure Adherence to Formularies

Executive Summary

Our review of SilverScript Insurance Company (SSIC), a Medicare Part D sponsor, found that SSIC's claims for prescription drug event data generally complied with Federal requirements regarding drugs that are provided to beneficiaries but that are not included in a sponsor's Part D plan formulary (non-formulary drugs). Based on our review of 100 claims, 1 claim was unallowable because the prescription was filled outside the allowable transition fill period. Because this is below the threshold of six errors needed for a statistical projection, we have no findings.

The Part D program allows Part D plan sponsors to choose whether or not they will use a formulary to administer their Part D plans. Sponsors that use a formulary must comply with certain statutory and regulatory requirements governing formulary operation. In certain circumstances, sponsors that use a formulary can submit claims for non-formulary drugs for Part D coverage. If these circumstances are not met, the Part D program does not permit reimbursement for these non-formulary drugs.

This report has no recommendations.

Complete Report

Download the complete report

Adobe® Acrobat® is required to read PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.

I'm Looking For

Let's start by choosing a topic

Exclusions Database Report Fraud
Newsletter Sign Up Envelop Graphic

Stay up to date on the latest OIG news and opinions

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201